Public Meeting Notice

Public Meeting Notice  Board of Registration in Pharmacy (via Webex) — Thursday, May 2, 2024

Thursday, May 2, 2024 at 8:00 a.m.
Posted: April 9, 2024 3 p.m.

Overview   of Board of Registration in Pharmacy (via Webex) — Thursday, May 2, 2024

A meeting of the Board of Registration in Pharmacy: This meeting is open to the public by Webex or telephone.

Join by Webex

Join by telephone

  • +1-617-315-0704 United States Toll (Boston)
  • +1-650-479-3208 United States Toll
  • Access code: 2537 378 1431

If you need reasonable accommodations in order to participate in the meeting, contact the DPH ADA Coordinator Erin Bartlett, erin.bartlett2@mass.gov or 857-262-7431 in advance of the meeting. While the Board will do its best to accommodate you, certain accommodations may require distinctive requests or the hiring of outside contractors and may not be available if requested immediately before the meeting. 

Agenda

Item

8:00

I

CALL TO ORDER

8:05

II

APPROVAL OF AGENDA

8:10

III

APPROVAL OF BOARD MINUTES

  • Draft of April 4, 2024, Regular Session Minutes

8:15

IV

REPORTS

  • Applications approved pursuant to Licensure Policy 13-01
  • Monthly report from Probation         
  • Board Delegated Review pursuant to Licensure Policy 14-02
  • PSUD Report-Policy 17-03

8:20

V

FLEX

  • NABP District 1 & 2 meeting; October 7-9, 2024 - Everett, MA
  • Memo: Non-Resident Pharmacy Inspection Requirements for Licensure
  • Pharmacy Advisory Committee Meeting:  June 12, 2024, 9am – 10am
  • Recommendation Document 24-01: Implantable Infusion Pumps
  • Election of Board member to the meeting
  • Notice of Opportunity re: Inspections

8:30

VI

POLICIES

  • Policy 13-01: Licensure Applications and Notices
  • Policy 14-02: Board Delegated Review (BDR)
  • Policy 2023-07: Non-Sterile Compounding
  • Rescind Policy 2019-03: Non-Resident Pharmacy Inspection Requirements for Licensure 

8:45

VII

APPLICATIONS

  •  SCCHC Pharmacy – Transfer of Ownership
  • Vantive US Healthcare-DS100105 - Relocation 
  • Cardinal Health; WD Renovation
  • Lowell Community Health Center Pharmacy – New Community Pharmacy

9:15

VIII

RECONSIDERATION

  • Walgreens #12869, DS89777 - PHA-2023-0185

9:30

IX

FILE REVIEW

1

CASE-2023-0782

INV8911

Stop & Shop #782, DS2299

2

CAS-2023-0418

PHA-2024-0017

Adam Smith, PH234871

3

CASE-2024-0013

PHA-2024-0004

Fisher Healthcare, Fisher Scientific, WD509

4

CASE-2024-0081

PHA-2024-0009

Walgreens #17980, DS90208

5

CASE-2023-0786

PHA-2023-0273

Walgreens #19437, DS90187

6

CASE-2024-0939

PHA-2024-0027

Walgreens #19437, DS90187

7

CASE-2024-0070

PHA-2024-0029

Ash Pharmacy, DS90361

8

CASE-2024-0124

PHA-2024-0041

Springfield Pharmacy, DS90286

9

CASE-2023-0656

PHA-2023-0240

Eastern Pharmacy, DS90270

10

CASE-2023-0745

PHA-2023-0264

Eastern Pharmacy, DS90270

11

CASE-2023-0712

PHA-2023-0261

Walgreens #7703, DS3383

12

CASE-2024-0129

PHA-2024-0037

Walmart 10-2904, DS2977

13

CASE-2023-0002

INV9194

CAPS Inc, Woburn

14

CASE-2023-0521

INV8330

Freedom Fertility, DS89717

15

CASE-2024-0080

PHA-2024-0006

Walgreens #17259, DS90362

16

CASE-2024-0008

PHA-2024-0021

CVS #1866, DS2956

17

CASE-2024-0943

PHA-2024-0030

CVS #859, DS3618

18

CAS-2023-1148

PHA-2024-0032

CVS #1900, DS3193

19

CASE-2023-0710

PHA-2023-0254

CVS #316, DS89941

11:00

X

EXECUTIVE SESSION

The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, evaluate the Good Moral Character as required for registration for a pending applicant. The

12:00

LUNCH BREAK

12:00

XI

M.G.L. c. 112, § 65C SESSION

4:00

XII

ADJOURNMENT

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback